Literature DB >> 21301374

Severe atrophic vaginitis causing vaginal synechiae and hematocolpos at menopause.

Saya Segal1, Heidi S Harvie, Evan Siegelman, Lily A Arya.   

Abstract

OBJECTIVE: Vaginal atrophy caused by decreased levels of ovarian estrogen production is common at menopause. Atrophic vaginitis severe enough to result in vaginal stricture of the upper two thirds of the vagina and subsequent hematocolpos is unusual.
METHODS: A 53-year-old woman presented with nonvisualization of the cervix at the time of her annual examination.
RESULTS: Pelvic ultrasound reported a "vaginal cyst," and the final diagnosis of hematocolpos was made by magnetic resonance imaging. The woman was managed with surgical excision of vaginal synechiae followed by local vaginal estrogen therapy and dilators, with satisfactory results.
CONCLUSIONS: Untreated severe atrophic vaginitis at menopause can result in a shortened vagina and hematocolpos. Magnetic resonance imaging is useful to characterize vaginal pathology in postmenopausal women.

Entities:  

Mesh:

Year:  2011        PMID: 21301374     DOI: 10.1097/gme.0b013e3181f3285a

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  3 in total

1.  A study on vaginitis among pregnant and non-pregnant females in Alexandria, Egypt: An unexpected high rate of mixed vaginal infection.

Authors:  Sherine Mohamed Shawaky; Mariam Majed Ali Al Shammari; Manal Shafik Sewelliam; Abeer Abd El Rahim Ghazal; Ahmed Noby Amer
Journal:  AIMS Microbiol       Date:  2022-05-05

2.  Complete vaginal outlet stenosis in a patient with Sheehan's syndrome.

Authors:  Minji Choo; Hana Park; Kyong Wook Yi
Journal:  Obstet Gynecol Sci       Date:  2016-11-15

Review 3.  Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women.

Authors:  Rossella E Nappi; Ellis Martini; Laura Cucinella; Silvia Martella; Lara Tiranini; Alessandra Inzoli; Emanuela Brambilla; David Bosoni; Chiara Cassani; Barbara Gardella
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-21       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.